20 LATEST RESOURCES (206 INDEXED)
Dextromethorphan-Bupropion (Auvelity) for the Treatment of Major Depressive Disorder · July 2023
Articles
Clinical Psychopharmacology and Neuroscience
Naltrexone Plus Bupropion Combination Medication Maintenance Treatment for Binge-Eating Disorder Following Successful Acute Treatments: Randomized Double-Blind Placebo-Controlled Trial · June 2023
Articles
Psychological Medicine
Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity · June 2023
Articles
Antioxidants
Improvement of Depressive Symptoms, After a Suicide Attempt, with Dextromethorphan/Bupropion Combination Treatment in a Patient with Treatment-Resistant Depression and Psychiatric Comorbidities · March 2023
Articles
Clinical Case Reports
Does Bupropion Increase Anxiety? A Naturalistic Study Over 12 Weeks · March 2023
Articles
Journal of Clinical Psychopharmacology
Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review · September 2022
Articles
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
The Relationship between Early Weight Loss and Weight Loss Maintenance with Naltrexone-Bupropion Therapy · May 2022
Articles
eClinicalMedicine
Clinical Uses of Bupropion in Patients with Parkinson’s Disease and Comorbid Depressive or Neuropsychiatric Symptoms: A Scoping Review · May 2022
Articles
BMC Neurology
Evaluating the Effectiveness of Bupropion and Varenicline for Smoking Cessation Using an Internet-Based Delivery System: A Pragmatic Randomized Controlled Trial (MATCH Study) · February 2022
Abstracts
Drug and Alcohol Dependence
Pregnancy Has No Clinically Significant Effect on the Pharmacokinetics of Bupropion or Its Metabolites · December 2021
Abstracts
Therapeutic Drug Monitoring
Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004 · December 2021
Articles
Journal of Clinical Oncology
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-On to Olanzapine or Risperidone in Overweight Individuals with Schizophrenia · November 2021
Abstracts
Journal of Clinical Psychopharmacology
Extended-Release Naltrexone/Bupropion Is Safe and Effective among Subjects with Type 2 Diabetes Already Taking Incretin Agents: A Post-Hoc Analysis of the LIGHT Trial · June 2021
Articles
International Journal of Obesity
Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia) · April 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/Bupropion as Add-On to Antidepressant Therapy in Patients with Obesity or Overweight · April 2021
Articles
Journal of Affective Disorders
Bupropion for Treatment Resistant Depression · April 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Treatment of Severe Morning Sleep Inertia with Bedtime Long-Acting Bupropion and/or Long-Acting Methylphenidate in a Series of 4 Patients · April 2021
Articles
Journal of Clinical Sleep Medicine
Development of Insomnia Associated with Different Formulations of Bupropion · February 2021
Articles
Primary Care Companion for CNS Disorders
Placebo-Controlled Trial of Bupropion for Smoking Cessation in Pregnant Women · January 2021
Abstracts
American Journal of Obstetrics and Gynecology